HVS Hospitals Expands Heart & Vascular Care Across Mumbai HVS Hospitals marks 10 years with a major expansion in Mumbai, now operating four centers offering world-class cardiac and vascular care in key suburbs. Read Full Story
Medlr Top 19 most selling medicines in India 2025 The Indian pharmaceutical market in 2025 is dominated by high-demand medicines across various therapeutic categories. From antibiotics to diabetes care, these top 19 best-selling drugs highlight the nation's evolving healthcare landscape.
Medlr Top 8 Government Hospitals of India 2025 India's top government hospitals in 2025 set benchmarks in healthcare, offering advanced treatments, research excellence, and quality patient care.
medlr news Eli Lilly Introduces Mounjaro in India for Obesity and Type 2 Diabetes Eli Lilly introduces Mounjaro (tirzepatide) in India, a dual GIP and GLP-1 receptor agonist designed for chronic weight management and type 2 diabetes.
medlr news BorderPlus and NSDC Collaborate to Empower Indian Healthcare Workers for Global Careers BorderPlus partners with NSDC to equip Indian healthcare workers with German language training, opening career opportunities in Germany and the DACH region.
medlr news TERN Group Expands Indo-German Healthcare Workforce Mobility with AI-Driven Ethical Recruitment TERN Group’s AI-powered Talent Tour connects Indian nurses with German hospitals, fostering ethical migration and workforce development.
medlr news AiMeD Advocates Balanced Tariff Policies to Strengthen India’s Healthcare Security AiMeD calls for a reassessment of India's medical device tariffs and regulatory barriers to strengthen domestic manufacturing and healthcare security.
medlr news Cellogen Therapeutics Secures Patent for India’s First Bi-Specific CAR T Cell Therapy Cellogen Therapeutics achieves a breakthrough with India’s first Bi-Specific CAR T cell therapy, offering a cutting-edge solution for blood cancers.
medlr news Aerogen Expands to India with New Headquarters to Advance Respiratory Care Aerogen establishes its India headquarters in Delhi, aiming to enhance respiratory care with advanced aerosol drug delivery technology. This expansion supports India’s growing healthcare needs, focusing on COPD treatment and strengthening global medtech collaboration.
medlr news Supriya Lifescience Expands Solar Capacity with New 5 MWp Facility Supriya Lifescience strengthens its sustainability efforts with a new 5 MWp solar facility in Maharashtra, increasing its total solar capacity to 9.85 MWp. This initiative supports India’s renewable energy goals while enhancing energy efficiency in pharmaceutical manufacturing.
medlr news Infinx Acquires Glidian to Enhance Prior Authorization and Patient Access Solutions Infinx has acquired Glidian to enhance AI-driven prior authorization and patient access solutions, expanding its reach in the laboratory market.
Medlr Top 7 Fortis Hospital in India 2025 Fortis Healthcare stands at the forefront of India's medical excellence. Discover the top 7 Fortis Hospitals in India for 2025, renowned for innovation, expertise, and superior patient care.
Medlr Top 7 Apollo Hospitals in India 2025 Discover the top 7 Apollo Hospitals in India for 2025, renowned for their advanced medical technology, expert care, and excellence in healthcare services.
Medlr Top 7 MAX Hospitals in India 2025 Discover the top 7 Max Hospitals in India for 2025, offering world-class healthcare with cutting-edge technology and expert medical professionals.
medlr news Peptris Technologies Licenses India’s First AI-Discovered Drug to Revio Therapeutics Peptris Technologies partners with Revio Therapeutics to advance PEPR124 (RT001), India’s first AI-discovered drug candidate for Duchenne muscular dystrophy (DMD). The agreement accelerates AI-driven drug discovery and expands global biotech reach.
medlr news India’s First Resuscitation Academy Opens in Hyderabad with Leadership Workshop Hyderabad hosts India’s first Resuscitation Academy, aiming to improve cardiac arrest survival rates through expert-led training and global collaboration.
Medlr Top 8 Knee Replacement Centers in India 2025 India's top 8 knee replacement centers in 2025, renowned for expert surgeons, advanced technology, and exceptional orthopedic care.
Medlr Top 6 Knee Replacement Surgeons in India 2025 Looking for the best knee replacement surgeons in India? Here are six top experts renowned for their advanced techniques, experience, and patient care in 2025.
medlr news Shilpa Medicare Introduces Hybrid CDMO Model at DCAT 2025 Shilpa Medicare introduces its hybrid CDMO at DCAT 2025, offering a dual-service model with tailored development partnerships and exclusive B2B licensing, enabling pharma companies to accelerate market entry while leveraging Shilpa’s expertise in oncology, biologics, and peptide manufacturing.
Medlr Top 21 Most Advanced Hospitals in India 2025 Discover the top 21 most advanced hospitals in India for 2025, featuring state-of-the-art technology, top-tier infrastructure, and expert healthcare.
medlr news India’s First Intestinal Rehabilitation Centre Opens in Mumbai Rela Hospital introduces India’s first Intestinal Rehabilitation Centre, offering specialized medical, surgical, and nutritional care for children with intestinal failure and complex gastrointestinal conditions.
medlr news Zydus Acquires 86% Stake in Amplitude Surgical: A Strategic Move in MedTech Zydus Lifesciences is set to acquire 86% of Amplitude Surgical, strengthening its presence in MedTech with innovative orthopedic solutions.
healthcare news Poly Medicure Achieves EU MDR Certification for 54 Medical Devices Poly Medicure secures EU MDR certification for 54 medical devices, reinforcing its commitment to quality, safety, and innovation in the European market.
Medlr Tenthpin Establishes AI Lab in Hyderabad to Transform Life Sciences Tenthpin AI Labs in Hyderabad aims to revolutionize life sciences by integrating AI into pharma, MedTech, and biotech, accelerating innovation and research.
healthcare news Glenmark Launches Glempa Range to Combat Diabetes and Heart Disease Glenmark introduces Glempa, a new range of Empagliflozin-based medications to manage type 2 diabetes and cardiovascular risks, offering flexible treatment options for better health outcomes.
